T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.85% |
| 2 | Technology | 18.49% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 14.06% |
| 5 | Communication Services | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Quanta Services
PWR
$104B
| $8.51M | ﹤0.01% |
282,780
| – | – |
|
|
DESP
1327
DELISTED
Despegar.com
DESP
| $8.44M | ﹤0.01% |
679,909
-208,460
| -23% | -$3.15M |
|
1328
Goodyear
GT
$1.76B
| $8.42M | ﹤0.01% |
412,394
+4,300
| +1% | +$93.1K |
|
1329
Qiagen
QGEN
$8.91B
| $8.34M | ﹤0.01% |
228,384
+106,709
| +88% | +$3.96M |
|
|
FOLD
1330
DELISTED
Amicus Therapeutics
FOLD
| $8.29M | ﹤0.01% |
865,277
-1,623,357
| -65% | -$17.8M |
|
1331
OGE Energy
OGE
$9.78B
| $8.27M | ﹤0.01% |
210,926
+5,909
| +3% | +$227K |
|
|
ACIA
1332
DELISTED
Acacia Communications Inc
ACIA
| $8.26M | ﹤0.01% |
+217,370
| New | +$8.78M |
|
1333
Viavi Solutions
VIAV
$10.6B
| $8.24M | ﹤0.01% |
820,331
-469,576
| -36% | -$5.07M |
|
|
USX
1334
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $8.09M | ﹤0.01% |
1,441,423
+639,551
| +80% | +$5.37M |
|
1335
CareDx
CDNA
$2.36B
| $8.06M | ﹤0.01% |
+320,688
| New | +$8.24M |
|
1336
Helmerich & Payne
HP
$4.43B
| $8.01M | ﹤0.01% |
167,004
-19,800
| -11% | -$1.22M |
|
1337
Synaptics
SYNA
$4.23B
| $7.98M | ﹤0.01% |
214,553
+4,228
| +2% | +$159K |
|
1338
Leggett & Platt
LEG
$1.33B
| $7.98M | ﹤0.01% |
222,666
| – | – |
|
|
YMAB
1339
DELISTED
Y-mAbs Therapeutics
YMAB
| $7.92M | ﹤0.01% |
389,497
+97
| +0% | +$2.23K |
|
1340
Standex International
SXI
$3.98B
| $7.69M | ﹤0.01% |
114,510
-999
| -0.9% | -$83.7K |
|
|
ZAYO
1341
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $7.63M | ﹤0.01% |
334,168
+21,816
| +7% | +$597K |
|
1342
Xerox
XRX
$407M
| $7.62M | ﹤0.01% |
385,740
| – | – |
|
1343
Helix Energy Solutions
HLX
$1.54B
| $7.58M | ﹤0.01% |
+1,401,901
| New | +$11.4M |
|
1344
ProQR Therapeutics
PRQR
$258M
| $7.58M | ﹤0.01% |
+480,425
| New | +$8.82M |
|
1345
Williams-Sonoma
WSM
$28.7B
| $7.5M | ﹤0.01% |
297,210
+2,786
| +0.9% | +$79.7K |
|
1346
Fluor
FLR
$7.08B
| $7.48M | ﹤0.01% |
232,424
-100
| -0% | -$4.31K |
|
1347
Coherus Oncology
CHRS
$182M
| $7.45M | ﹤0.01% |
823,661
-449,658
| -35% | -$5.2M |
|
|
VRAY
1348
DELISTED
ViewRay, Inc.
VRAY
| $7.42M | ﹤0.01% |
1,222,984
+623
| +0.1% | +$4.67K |
|
|
TPIC
1349
DELISTED
TPI Composites
TPIC
| $7.42M | ﹤0.01% |
301,682
+158,274
| +110% | +$4.03M |
|
1350
Corvus Pharmaceuticals
CRVS
$1.27B
| $7.29M | ﹤0.01% |
1,986,163
-2,010
| -0.1% | -$13.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.